Global Orthokeratology Market Size, Share, Growth Analysis Report - Forecast 2034

Global Orthokeratology Market: Industry Perspective

The global orthokeratology market size was worth around USD 861.8 Million in 2024 and is predicted to grow to around USD 1699.44 Million by 2034 with a compound annual growth rate (CAGR) of roughly 6.5% between 2025 and 2034. The report analyzes the global orthokeratology market's drivers, restraints/challenges, and the effect they have on the demands during the projection period. In addition, the report explores emerging opportunities in the orthokeratology industry.

Request Free Sample

Global Orthokeratology Market: Overview

Orthokeratology is also known as ortho-K. It is a non-surgical and non-invasive medical procedure in which specially designed lenses known as ortho-k are fitted in a patient’s eyes. The ortho-k lens is not permanently implanted but temporarily. It helps in reshaping the cornea or improving vision. Once the end goal is achieved, the lens implants are removed. In medical terms, it can be compared to dental braces. The primary function of ortho-k procedures is to improve myopia which causes near-sightedness. Although there are several other ways to treat myopia such as Laser-Assisted In Situ Keratomileusis (LASIK), most alternate options are surgical procedures which is one of the main reasons for higher preference for ortho-K in countries with higher patient awareness and greater access to non-invasive medical procedures. However, ortho-k lenses also have certain specific drawbacks associated with them which are currently acting as growth barriers. During the forecast period, the orthokeratology industry is expected to grow at a steady momentum.

Global Orthokeratology Market: Growth Drivers

Rising cases of myopia to drive market growth

The global orthokeratology market is expected to grow owing to the rising number of people with near-sightedness or myopia. It is a common sight-related medical condition causing objects placed near the eyes to appear clear but the ones placed farther away appear blurred. The condition starts to develop during childhood or adolescence and tends to become stable when a person reaches the age of 20 to 40 years. Myopia is caused when the condition or shape of the cornea causes inaccurate focusing of the light that is passing through the eye. In some cases, the refractive error can be caused by the eye shape itself. Several risk factors are associated with the condition including genetics, environmental conditions, screen time, and prolonged close-up activities. As per reports published by the International Myopia Institute around 30% of the world’s population is currently myopic and the statistics are expected to reach 50% by 2050.

Growing demand for non-invasive medical procedures to create a higher consumption rate

Orthokeratology is a non-invasive medical procedure using customized ortho-k lenses to improve the shape of the cornea or sight issues. Ortho-K lenses are typically to be overnight when the patient is sleeping. They are rigid and gas-permeable lenses that can support cornea reshaping while allowing oxygen entry into the eyes keeping them healthy. Other cornea-correcting medical procedures typically involve some form of surgery and there is a growing demand for non-invasive medical procedures especially for extremely sensitive body parts such as the eyes. The growing solution awareness as well as the comfort offered by ortho-k lenses is projected to drive global orthokeratology market growth to new heights during the forecast period.

Restraints:

Complication risks associated with ortho-k lenses could restrict market growth

The demand for ortho-k medical processes may be restricted owing to the several risks associated with the lenses. For instance, some of these risks are similar to the ones when normal lenses are worn including the risk of eye infection. Children are more vulnerable to these risks if they do not practice good contact lenses and clean hand hygiene. In addition to this, several people across the globe are not comfortable with touching the eye or the area around it directly. Using ortho-k lenses requires some amount of training and a large segment of potential consumers may be unwilling to use these lenses. In case the patient is unable to adhere to wearing ortho-k lenses every day until prescribed, the results may not be evident leading to patient non satisfaction with the treatment further limiting growth in the ortho-k industry.

Opportunities:

Growing research and development to improve lens efficiency to create growth opportunities

The orthokeratology industry growth is projected to witness excellent growth opportunities resulting from the ongoing extensive research and development to understand and improve the overall lens efficiency in dealing with incorrect cornea structure or myopia. In July 2023, the Review of Cornea & Contact Lenses (RCCL) published a report stating that ortho-K was more effective in children as compared to adults. The research concluded that younger children registering early onset of myopia when treated with ortho-k lenses have an excellent chance of curbing condition progression. Another published research finding by RCCL during the same month concluded that combining ortho-k treatment with atropine can temporarily improve myopia slowdown. However, more research and studies are needed to reach a final conclusion. The rising number of new solutions with higher efficiency will also help in delivering new expansion avenues to the orthokeratology industry players. Recently, GP Specialists, a leading manufacturer of ortho-k products, launched iSee Ortho-k lens, an advanced ortho-k lens design. The lens is influenced by the United States Food and Drug Administration (FDA)-approved FARGO ortho-k contact lens.

In September 2024, Scotlens, a contact lens-specializing company, announced a partnership with Avizor. The companies jointly launched the ‘unboxing experience’ with the intention of creating mass public awareness about ortho-k night lenses. The companies expected to create patient excitement upon receiving their ortho-k lenses.

Challenges:

Growing demand for alternate solutions to challenge market growth

Several other medical procedures are available in the market to treat myopia and improve cornea structure. For instance, the most simple and widely prevalent solution is wearing optician or medically-recommended eyeglasses. These medical instruments are highly effective and do not require the patient to undergo any form of surgical or non-surgical medical procedure. A report by The Vision Council claimed that nearly 64% of all adults wore some form of eyeglasses while at least 11% were accustomed to wearing contact lenses. There is significant demand for certain surgical procedures as well including LASIK. These factors are likely to create challenges in the orthokeratology industry.

Key Insights

• As per the analysis shared by our research analyst, the global orthokeratology market is estimated to grow annually at a CAGR of around 6.5% over the forecast period (2025-2034).
• Regarding revenue, the global orthokeratology market size was valued at around USD 861.8 Million in 2024 and is projected to reach USD 1699.44 Million by 2034.
• The orthokeratology market is projected to grow at a significant rate due to rising prevalence of myopia, especially among children and adolescents, increasing demand for non-surgical vision correction methods, advancements in lens technology enhancing comfort and effectiveness, and growing awareness of myopia control solutions.
• Based on Product Type, the Day-time Ortho-K Lenses segment is expected to lead the global market.
• On the basis of Application, the Myopia segment is growing at a high rate and will continue to dominate the global market.
• Based on the End User, the Hospitals segment is projected to swipe the largest market share.
• Based on region, North America is predicted to dominate the global market during the forecast period.

Global Orthokeratology Market: Report Scope

Global Orthokeratology Market: Segmentation Analysis

Request Free Sample

The global orthokeratology market is segmented based on Product Type, Application, End User, and region. All the segments have been analyzed based on present and future trends and the market is estimated from 2025 to 2034.

Based on Product Type, the global orthokeratology market is divided into Day-time Ortho-K Lenses, Overnight Ortho-K Lenses.

On the basis of Application, the global orthokeratology market is bifurcated into Myopia, Presbyopia, Hypermetropia, Astigmatism.

By End User, the global orthokeratology market is split into Hospitals, Optometry Clinics, Ophthalmology Clinics, Others.

The Regional, this segment includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America,and the Middle East and Africa.

Global Orthokeratology Market: Regional Analysis

North America to register the highest growth rate during the assessment timeframe

The global orthokeratology market is expected to witness the highest growth rate in North America. It controlled around 37.52% of the final global revenue in 2022. Factors driving regional growth are higher product awareness and a rising number of ortho-k lens providers in addition to an increasing number of new product launches. In November 2024, Johnson & Johnson Vision, a leading player in eye health, announced that it had received FDA approval for the sale of ACUVUE® Abiliti™ Overnight Therapeutic Lenses meant for managing myopia. These are custom-made lenses and are highly effective in reshaping the cornea. The rising number of myopic patients in the US is expected to benefit from the launch. In May 2024, Euclid Systems Corporation launched the Euclid MAX OrthoK lenses with FDA approval. Asia-Pacific is expected to register higher revenue driven by an increasing number of people with near-sightedness. For instance, in developed countries of Southeast and East Asia, myopia prevalence rate is around 80 to 90% in young adults.

Global Orthokeratology Market: Competitive Analysis

The report provides a company market share analysis to give a broader overview of the key market players. In addition, the report also covers key strategic developments of the market, including acquisitions & mergers, new product launches, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the orthokeratology market on a global and regional basis.

The global orthokeratology market is dominated by players like:

• Paragon Vision Sciences
• Bausch + Lomb
• Euclid Systems Corporation
• GP Specialists
• Art Optical Contact Lens Inc.
• Menicon Co. Ltd.
• CooperVision
• Visionary Optics LLC.
• E&E Optics
• Brighten Optix

Global Orthokeratology Market: Segmentation Analysis

The global orthokeratology market is segmented as follows;

By Product Type

• Day-time Ortho-K Lenses
• Overnight Ortho-K Lenses

By Application

• Myopia
• Presbyopia
• Hypermetropia
• Astigmatism

By End User

• Hospitals
• Optometry Clinics
• Ophthalmology Clinics
• Others

Global Orthokeratology Market: Regional Segment Analysis

• North America
  • The U.S.
  • Canada
  • Mexico
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
• The Middle East & Africa
  • Saudi Arabia
  • UAE
  • Egypt
  • Kuwait
  • South Africa
  • Rest of the Middle East & Africa
• Latin America
  • Brazil
  • Argentina
  • Rest of Latin America